• 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai  |   Westin Mumbai Garden City
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai  |   Westin Mumbai Garden City
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai  |   Westin Mumbai Garden City
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai  |   Westin Mumbai Garden City
  • 6th ANNUAL PHARMA GMP & QUALITY MANAGEMENT 2026
    23rd - 24th April, Mumbai  |   Westin Mumbai Garden City

About the event

Following the resounding success of its 5th edition, Eminence Business Media proudly presents the 6th Annual Pharma GMP and Quality Management 2026, scheduled for 23rd - 24th April at The Westin Mumbai Garden City.

This confluence is dedicated to fostering the exchange of knowledge, embracing best practices, and enhancing the capabilities of pharmaceutical companies in India, empowering them to adopt globally recognized standards with a strong emphasis on the technical intricacies of pharmaceutical manufacturing and quality assurance. This highly anticipated occasion will provide a comprehensive platform for industry experts to converge and delve deep into the technical nuances of Good Manufacturing Practices (GMP) and quality management.

The session is aiming to showcase in-depth discussions and immersive training sessions led by renowned thought leaders and practitioners to gain practical, technical skills and knowledge essential for ensuring compliance, product quality, and operational efficiency in pharma manufacturing.

To enhance the learning experience and better understanding and implementation, a virtual session is to take place on 23rd - 24th April, 2026 with additional presentation and follow up question answer round with 3 industry experts.

Let's connect and collaboratively shape the success of the 6th Annual Pharma GMP and Quality Management 2026.

The conference is co-located with The Pharma Quality Excellence Awards 2025 at The Westin Mumbai Garden City.



Benefits of Partnering

Access to Decision Makers and Influencers: 150+ decision-makers and influencers in the conference hall can lead to potential collaborations, partnerships, and business opportunities.
International and Indian Pharma Companies Networking: Opens doors to global markets, foster cross-border collaborations, and facilitate knowledge exchange on a global scale.
Extensive Media Coverage: Enhance the visibility of partnering companies and position yourself as a market leader.
Post-Event Assistance and Support: Includes follow-up meetings, additional information sharing, and assistance in navigating post-conference business transactions, strengthening the value of the partnership.
Focused Networking Opportunities: Engage with specific individuals or companies relevant to their business goals, optimizing their networking efforts for targeted outcomes.
Limited Vendors from the Same Category: Exclusivity can enhance the visibility of each vendor and prevent saturation, making the partnership more valuable for participants.

Why Attend?

  • In-depth discussions, case studies, group discussions and dedicated Q&A session for enhanced practical learning.
  •  Explore the impact of recent innovations in GMP & Quality Management 
  • Gain insights through interactive live Q&A sessions and enjoy the advantage of extended 6-month support for continuous learning.
  • Follow up virtual learning session with presentations and dedicated Q&A round 15 days after the conference.
  •  Network with your industry peers and understand what they do differently

Attendee Profile ?

Managing Directors, Directors, CXO’s, President, Sr. VP’s, VP’s, GM’s, Sr. Managers Managers and professionals from:

Quality Assurance
Quality Control
Quality Compliance
Clinical Trials/Clinical Quality/Clinical Operations
Regulatory Affairs
Quality Audits
Anyone who follows, and has to be compliant with GMP, GCP & Quality Management regulations.

Pricing

$ 1200 / INR 50,000

Standard Pricing

  • + 18% GST applicable
$ 1350 / INR 60000

Onsite Registration

  • + 18% GST applicable

*These prices are applicable for pharmaceutical companies only.

SPEAKERS

Ken Shitamoto

America's Steering Committee Member
FDA Industry CSA Team
And GAMP

View Profile
×
Ken Shitamoto

Ken Shitamoto

America's Steering Committee Member – FDA Industry CSA Team And GAMP

Ken Shitamoto is a technology and quality leader with more than 30 years of experience in the pharmaceutical industry, including roles at Genentech, United Biosource Corporation, and Gilead. His work focuses on modernizing quality and validation practices for regulated computerized systems, emphasizing risk-based approaches and software quality engineering.
Ken actively contributes to the global industry through organizations such as the FDA Industry CSA (FICSA) team and the GAMP Americas Steering Committee. As a member of FICSA and co-lead of GAMP's Computer Software Assurance Special Interest Group, he is helping advance the practical implementation of modern assurance and validation practices. He has also contributed to industry guidance publications including GAMP 5 Second Edition, Enabling Innovation, and Data Integrity by Design.

Milind Goverdhan Gujar


Chief Quality Officer
RPG Life Sciences Ltd.

View Profile
×
Milind Gujar

Milind Goverdhan Gujar

Chief Quality Officer – RPG Life Sciences Ltd.

Milind Goverdhan Gujar is the Chief Quality Officer (QA & QC) at RPG Life Sciences Ltd., where he has been a member of the Executive management committee since 2019. He is a seasoned pharmaceutical quality professional with over 37 years of experience in Active Pharmaceutical Ingredients (API), Bio technology and Formulation quality functions.
Holding an Masters in Analytical Chemistry, Milind has worked in various capacities within the quality sector at multiple reputable organizations, including Emcure, Micro Labs, Reliance Life Sciences, Cipla, Famy care and Ipca, prior to joining RPG Life Sciences His extensive professional experience covers API, Formulations, and Biopharmaceutical products.
Milind is recognized for his expertise in handling digitalization projects for large organizations, such as implementing Track and Trace, Trackwise, LIMS, and paperless laboratory concepts along with Quality function.
He has also handled various green field and brown field projects for his previous organisation specifically oncology and hormone projects. He has successfully managed a significant number of audits from global regulatory bodies, including the USFDA, EDQM, EUGMP, MHRA, WHO Geneva, Anvisa Brazil and Health Canada. He is also an invited speaker at various seminars, particularly on the topics of Quality and the Digitalization of Quality Management Systems (QMS)

Raj Kumar Patra

Vice President, Head of IT - Research and Discovery
Syngene

View Profile
×
Raj Kumar Patra

Raj Kumar Patra

Vice President, Head of IT - Research and Discovery, Syngene

With over two decades of Technology & Digital leadership in pharma and consumer healthcare, Raj Kumar Patra specializes in driving digital transformation, AI-powered innovation, and enterprise IT strategy to enable business growth, compliance, and operational excellence. As Head of IT for Research Services at Syngene International, he oversees portfolios spanning Chemistry, Biology, Clinical Research, Safety Assessment & Computational Data Science—integrating AI, data analytics, automation, cybersecurity, and cloud technologies to deliver transformative outcomes.
A strong advocate for AI and data-led decision-making, he has implemented predictive analytics and enterprise data governance strategies to enhance compliance, efficiency, and agility.
He thrives at the intersection of technology, business, and regulatory standards, shaping the future of enterprise IT.

Sanjay Sharma

Senior VP & Head – Manufacturing Science and Technology
Zydus Group

View Profile
×
Sanjay Sharma

Sanjay Sharma

Senior VP & Head – Manufacturing Science and Technology – Zydus Group

Sanjay Sharma, a future-ready CIO, aligns IT strategy with business growth and innovation. With 25 years of leadership in the pharmaceutical and manufacturing sectors, Sanjay brings deep expertise in driving digital transformation in highly regulated industries. He has successfully led large-scale technology initiatives, enabling organizations to unlock growth opportunities while ensuring compliance and operational excellence. Recognized as a trusted C-suite advisor, Sanjay specializes in shaping digital roadmaps, leveraging cutting-edge solutions, and delivering enterprise-wide transformation that creates lasting business value.

Sudhir Bhandare

Executive Director & Head of
Technical Operations
Sandoz

View Profile
×
Sudhir Bhandare

Sudhir Bhandare

Executive Director & Head of Technical Operations – Sandoz

Sudhir Bhandare is a seasoned pharmaceutical leader with over three decades of experience driving operational excellence and advancing access to high-quality medicines worldwide. A pharmacist by education (M.Pharm) with an MBA, he brings together deep technical expertise and strategic business acumen.
Throughout his career, Sudhir has evolved from strong technical foundations in pharmaceutical formulations to senior leadership roles marked by strategic vision, execution excellence, and transformative impact. He has led high-impact initiatives, strengthened operational performance, and mentored future leaders, consistently embracing change and growth at every stage of his professional journey.
Prior to his current role as Executive Director & Head of Technical Operations at Sandoz, Sudhir built a distinguished career with leading global pharmaceutical organizations including GSK (GlaxoSmithKline), Schering-Plough, Mylan, Novartis, Glenmark, and Ipca. His core expertise spans operational excellence, large-scale execution, and formulation science, underpinned by a strong commitment to quality and performance.
At the heart of Sudhir’s leadership philosophy is a powerful purpose: ensuring equitable access to affordable, high-quality medicines across geographies. He firmly believes that healthcare is a right, not a privilege, and is dedicated to bridging the gap between innovation and accessibility to improve the quality of human life globally.
Beyond the boardroom and manufacturing floor, Sudhir channels the same discipline and consistency into personal fitness—balancing his professional dedication to healing others with a personal commitment to self-improvement and well-being.

Dr. V. Kalaiselvan

Secretary-cum-Scientific Director
IPC, Ministry of Health & Family Welfare, Government of India

View Profile
×
Dr. V. Kalaiselvan

Dr. V. Kalaiselvan

Secretary-cum-Scientific Director – IPC, Ministry of Health & Family Welfare, Government of India

Dr. V. Kalaiselvan is currently serving as the Secretary-cum-Scientific Director of the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India. He holds a Ph.D. in Pharmaceutical Sciences from the University of Delhi. Dr. Kalaiselvan has been associated with IPC since 2009, contributing significantly to the domains of pharmacopoeial standards, rational use of medicines, drug safety, and regulatory systems.
He played a key role in the conceptualization and nationwide implementation of the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI), which have strengthened India’s surveillance framework for the safety of medicines and medical devices.
Dr. Kalaiselvan has represented IPC on various national and international platforms, including the World Health Organization (WHO), and continues to contribute to global initiatives for strengthening pharmacovigilance systems in low- and middle-income countries. In recognition of his work, the WHO Headquarters in Geneva acknowledged him as one of the significant contributors to global pharmacovigilance in their 50th Celebratory Album of the International Drug Monitoring Programme.
He has authored 11 chapters and published over 130 research and review articles in national and international journals. He is also a recipient of prestigious fellowships awarded by the Department of Science & Technology (DST) and the All India Council for Technical Education (AICTE).

Vipul Doshi


Chief Quality Officer
Zydus Group

View Profile
×
Vipul Doshi

Vipul Doshi

Chief Quality Officer – Zydus Group

Mr. Vipul Doshi has been in pharmaceutical Industry from more than four decades with diverse leadership and operational expertise across development, manufacturing, R&D, GXP quality assurance (QA) and manufacturing operations (parenterals, solid dosage forms, biotechnology, transdermal, biologics and vaccines).

He has been leading the Quality and Regulatory affairs function in the Pharmaceutical Companies of high credentials. Throughout his career he has been providing passionate global leadership and pioneered in guiding the companies to meet the Global Regulatory, Quality Standards and Compliance requirements.

He has been a Great Contributor in developing and implementing Quality attributes and Culture of Excellence based upon a set of core values and ethical practices, which integrate and improve business operations and enhance the compliance within the Organization.

He has been a leading advocate for Global Competitiveness and instrumental in due diligence for various acquisitions and mergers. He possesses great expertise in Projects and Engineering for developing Infrastructures for APIs and Drug Products (Sterile and Non Sterile). He has been actively involved with various professional associations like ISPE/PDA/AAM.

Associated with varied Roles and increasing responsibilities he is currently Chief Quality & Compliance Officer at Zydus Lifesciences Limited (Company has headquarters at Ahmedabad). He also Leads IRA, Research and Development functions for Active Pharmaceutical Ingredient, Environment Health & Safety and Pharmacovigilance.

Zydus Lifesciences Limited is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employees nearly 25000 people worldwide and is dedicated to creating healthier communities globally.

The Product portfolio ranges from Complex generics Sterile and Non Sterile, Biologics and Vaccines and various dosage forms catering to global market.

S. M. Mudda


Managing Director
Misom Labs Limited

View Profile
×
Vipul Doshi

S. M. Mudda

Managing Director – Misom Labs Limited

S. M. Mudda is a Pharmacy graduate with a Postgraduate Diploma in Management Studies and has over 42 years of extensive experience in the pharmaceutical industry, covering all aspects of pharmaceutical manufacturing. He spent more than 30 years with Micro Labs Limited, serving as Executive Director – Technical and Operations and later as Director – Global Strategies. He is currently the Managing Director of Misom Labs Limited, Malta, an EU GMP Licensed Pharmaceutical Testing Laboratory. He has also served as Ex-President – NSF Health Sciences (India), representing NSF International UK, a global GMP consulting and education company in the Asia Pacific region. In addition, he is the Program Director for NSF UK’s Advanced Program in Pharmaceutical Quality Management, offered in collaboration with the Indian Drug Manufacturers’ Association (IDMA) for senior industry executives. Actively involved with IDMA, he serves as Chairman of the Regulatory Affairs Committee and works as a Technical Advisor and Leadership Mentor to several leading Indian pharmaceutical companies.
Mr. Mudda’s key strengths include providing technical and strategic leadership for the design and operation of plants aligned with global standards for operations, quality, and compliance. Well-connected with national and global thought leaders in Pharmaceutical Quality Management and CGMP regulation, he specializes in designing and implementing best-in-class Quality Management Systems harmonized with global requirements. He has hosted over 70 GMP inspections conducted by leading regulatory agencies such as the US FDA, European agencies, and MHRA, and is recognized for creating global remediation plans with long-term, sustainable CAPAs to help companies avert regulatory actions.
Among his notable achievements, Mr. Mudda has designed world-class, GMP-compliant facilities for various dosage forms, including Oral Solid Dosage (general plants and dedicated facilities for Penicillins and Cephalosporins) and sterile products such as ophthalmic products in Blow-Fill-Seal packs and sterile powder for injections. These facilities, developed at Micro Labs Limited, Bangalore, and FDC Limited, Mumbai, have received approvals from major regulatory bodies including UK MHRA, US FDA, WHO, MCC South Africa, Health Canada, and ANVISA Brazil.
Mr. Mudda holds several memberships and recognitions, including Chairman of the Regulatory Affairs Committee of IDMA, former Director of ISPE (International Society of Pharmaceutical Engineers) – India Affiliate, and Life Member of the Indian Pharmaceutical Association (IPA). He is a former member of the Scientific Body of the Indian Pharmacopoeia Commission (IPC), nominated by the Ministry of Health, Government of India, and currently chairs the IPC’s Ophthalmic Committee. He has also served as a member of the Committee of Administration (COA) – Pharmexcil, India, and was part of the jury panel for the UBM India Pharma Awards from 2015 to 2018.
He has delivered numerous presentations on pharmaceutical manufacturing, quality, and compliance at national and international forums and academic institutions, participated in high-level panel discussions, and appeared on national television for a live interview on “Make in India – Role of Pharmaceutical Industry” in January 2016. Notably, he delivered a keynote address at NEXUS 16, an international Track-n-Trace conference in Boston, USA, and participated in the 10th Anniversary UBM CPhI CEO Round Table in Mumbai in 2016.

Dr. Ravi Kanta

Head Global External Supply Quality
and Compliance
Indoco Remedies Ltd

View Profile
×
Vipul Doshi

Dr. Ravi Kanta

Head Global External Supply Quality and Compliance – Indoco Remedies Ltd

Dr. Ravi Kanta is a seasoned quality professional with 02 decades of enriching experience within pharmaceutical domains. He has worked at Various Senior Leadership roles with reputed pharma companies covering multiple dosages form and technologies including complex products & technologies. Currently Dr. Ravi Kanta is working as Head Global External Supply Quality and Compliance at Indoco Remedies Ltd. His Previous assignment include major pharmaceutical companies like Sun Pharma and Zydus Life Sciences at Leadership level. He hold PhD from Kennedy University USA, Master in Pharmacy in Pharmaceutics from Preston University Australia, Bachelor of Pharmacy from Dr. A.P.J Abdul Kalam University India, MBA in Production Management, Total Quality Management and Six Sigma Black Belt certified professional. His Pharmaceutical industry career encompasses a depth of experiences in area of Quality Management System, Sustainable Quality Culture, Remediation, Sterility Assurance, Corporate Quality & Compliance, Quality Assurance, Quality Control, Microbiology, Operational Excellence, Inspection Management, Product Robustness, Data Assurance, Quality Risk Management, Quality Management Maturity, Cultural Transformation, Pharmaceutical cGMP for 21st Century, Advance Pharmaceutical manufacturing Strategies, Patient Centricity and Digital Transformation.

M. Suryanarayana Reddy

Senior Vice President
– API Quality
NATCO Pharma Ltd

View Profile
×
Vipul Doshi

M. Suryanarayana Reddy

Senior Vice President– API Quality – NATCO Pharma Ltd

M. Suryanarayana Reddy is a seasoned pharmaceutical quality leader with over 30 years of extensive experience in the API and pharmaceutical manufacturing industry. Currently serving as Senior Vice President – API Quality at NATCO Pharma Ltd, he plays a pivotal role in driving quality excellence, compliance, and operational efficiency across the organization.
Throughout his distinguished career, Mr. Reddy has worked with several leading global and Indian pharmaceutical companies including Dr. Reddy’s Laboratories, AstraZeneca, Alembic Pharmaceuticals, and Neuland Laboratories Ltd, before joining NATCO Pharma two years ago. His diverse industry exposure has enabled him to build deep expertise across multiple facets of pharmaceutical quality and operations.
Over the years, he has successfully led and managed key functions such as Corporate Quality, Site Quality, Supplier Quality, Quality Control, Development Quality, and Manufacturing Operations. He has also been instrumental in driving digital transformation and automation initiatives across quality systems, implementing platforms such as LIMS, QAMS, DMS, LMS, TrackWise, and E-Logbook to enhance compliance, efficiency, and data integrity.
Mr. Reddy holds a Postgraduate degree in Pharmaceutical Chemistry from BITS Pilani and an MBA, strengthening his blend of scientific and business leadership capabilities. Further enhancing his strategic leadership perspective, he has completed Strategic Leadership and Business Finance programs from premier institutions including ISB and IIM.
With his deep industry knowledge, leadership in quality management, and commitment to continuous improvement, Mr. Reddy continues to contribute significantly to advancing quality standards and operational excellence within the pharmaceutical sector.

Dr. Rupesh Kelaskar

Vice President of Corporate Quality Control & Analytical R&D
FDC Limited

View Profile
×
Vipul Doshi

Dr. Rupesh Kelaskar

Vice President of Corporate Quality Control & Analytical R&D – FDC Limited

Rupesh Chandrakant Kelaskar is a senior management professional with over 30 years of experience in Research and Development (R&D), Quality Assurance (QA), and Quality Control (QC) within the pharmaceutical and FMCG industries. He has a strong background in analytical method development, laboratory operations, and ensuring compliance with various international regulatory standards such as cGMP and USFDA guidelines.
Currently, he serves as the Vice President of Corporate Quality Control & Analytical R&D at FDC Limited, where he manages quality control functions across multiple sites, oversees laboratory operations, and ensures compliance with regulatory bodies. His career also includes roles at Apotex Research, IVAX India, and Norton Healthcare, where he led significant initiatives in method validation, lab operations, and quality control audits.
Rupesh holds a Ph.D. in Analytical Chemistry from the University of Mumbai and has undergone training in Artificial Intelligence and Machine Learning. He is well-versed in conducting vendor audits, developing quality systems, and optimizing laboratory productivity. His career highlights include managing multiple vendor and third party audits and playing a crucial role in launching new products through rigorous quality checks and R&D support.

Dr. Udaykumar Rakibe


Founder
PharmaMantra TM

View Profile
×

Dr. Udaykumar Rakibe

Founder – PharmaMantra TM

Dr. Udaykumar is a quality professional with a dynamic career steering organization through complex Quality & Regulatory challenges, transitions, building an empowered and talented workforce in the cross-cultural environment within highly competitive products and regulatory environment.
In Year 2006, as Director - Quality Assurance, he was mandated and given the task to execute and spearhead the proactive remediation at Ranbaxy Lab. Ltd. Subsequently since Daichii Sankyo takeover, he was made Head, India and Asia Quality Operations and overseeing the state of control. In late 2011 he was recruited by Intas Pharma Ltd. to create a self-sustaining quality management system.
Further, in 2013 he was hand-picked & recruited by Wockhardt Ltd., as Senior Vice President – Quality, to turn around the Quality Management, lead and manage the remediation of Quality initiatives. He has represented the Organisation as Quality Head and prepared, presented and attended the regulatory meetings with IAG/ MHRA/ IMB/ USFDA at London and Washington. Has performed 400+ Audits and faced 500+ regulatory audits.
He has founded the consulting firm, PharmaMantra, a Quality Advisory and consulting firm in August 2017. Since then he has performed Training, GAP assessment Audit, Site support during EDQM/ USFDA, Toxicological PDE Certification, and Consulting assignments for Indian and MNC clientele. He has proposed Corrective Action Plan and worked with senior management to maintain a culture of compliance and trust with regulators. He envisions thorough PharmaMantra, he shall be able to provide the Manufacturing and Quality Leaders the desired insights and advice to reach simple sustainable solutions for the seemingly complex situations/ problems/ activities. He has experience which can be shared and adopted for various stages of the Quality System developments and subsequent evolution to demonstrate the desired Culture of Pharmaceutical Quality.

Amit Malviya


Vice President Quality Assurance
Zest Pharma

View Profile
×

Amit Malviya

Vice President Quality Assurance – Zest Pharma

At Zest Pharma, leading as the Vice President Quality Assurance & at Emorphis Technologies, leading the role as a Technical Adviser in the Artificial Intelligence (AI) powered quality compliance software division.
I leverage over two decades of experience in the pharmaceutical industry, specializing in manufacturing, quality process improvement, and regulatory affairs. I am privileged to lead the quality team, and my thrust for research provides me the opportunity to lead F&D as well.
My tenure at Cipla Ltd. (Mumbai), Oman Pharmaceutical (Oman), and Intrinseque Healthcare Pte Ltd (Singapore) laid the foundation for my expertise in ensuring product quality and adherence to regulatory standards.
The dedication to excellence in my role reflects my commitment to advancing healthcare through stringent quality measures. My mission aligns with Zest Pharma's ethos of trust and integrity, and I continuously strive to uphold these values while fostering innovation and compliance in every aspect of our operations.

Key Skills:
• Knowledge and working experience with national & international quality standards and quality systems.
• Working/Regulatory Knowledge of USFDA, MHRA, EU, TGA, MCC, ANVISA, PPB, NAFDAC, EN ISO 13485:2016, WHO regulatory & cGMP requirements.
• Knowledge of Quality Tools, Root Cause Analysis, problem-solving techniques, Deviation Handling, Risk Management, CAPA, and Change Control Management.
• Preparation and heading of International Regulatory Inspections.
• Self-starter, dedicated, and highly skilled professional with a great passion for quality operations.
• Regulatory Audit Handled - USFDA, MHRA, MCC, ANVISA, TGA, GCC, MOH, PPB, NAFDAC, cGMP, WHO & EN ISO 13485:2016.
• Actively involved in development of Artificial Intelligence (AI) powered applications which are useful to handle the quality compliances in pharma manufacturing division.

Rama Venugopal

Executive Director
Value Added Corporate Services (P) Ltd

View Profile
×

Rama Venugopal

Executive Director - Value Added Corporate Services (P) Ltd

Ms. Rama Venugopal is the Executive Director of Value Added Corporate Services (P) Ltd., Chennai, a management consulting organization with over three decades of experience delivering strategic and operational consulting solutions across diverse sectors including manufacturing, healthcare, and IT/ITES. With nearly 30 years of consulting experience, she has played a pivotal role in helping organizations strengthen management systems, drive business transformation, and implement strategic advisory initiatives such as mergers and acquisitions, funding facilitation, and joint venture collaborations.
Ms. Venugopal brings over 30 years of expertise spanning marketing, sales, business development, and operations within the management consulting space. Her multidisciplinary experience enables her to guide organizations in aligning strategy with execution while building strong operational frameworks for sustainable growth.
She currently serves as the President of the Consultants Consortium of Chennai, an association representing management systems consultants and professionals dedicated to advancing standards, regulatory awareness, and conformity assessments. She is also actively involved with several industry and entrepreneurship initiatives.
Ms. Venugopal heads the Standards, Certifications and Regulations Sub-Committee at the Andhra Chamber of Commerce, a 97 year old chamber contributing to initiatives that strengthen entrepreneurial ecosystems.
A passionate supporter of the #MakeInIndia initiative, she represents the Association of Indian Medical Device Industry (AiMeD) as the South India Joint Coordinator. She also serves on the Advisory Board of Medical Fair India, initiative of Medicare Asia.
She is also an Advisor to Hospex Healthcare Expo, a platform by Doctors for Doctors to encourage, drive Healthtech , Medtech, Biotech Innovations from India globally.
She is also a Member of TiE Chennai where she has picked up a passion to Mentor Innovators.
She is also an Executive Member of FABA – The Federation of Asian Biotech Associations , a globally recognised platform connecting Academia, Industry, Startups, Govt bodies in Life Sciences. Also a Member of TxD 36 (Medical Textiles); MSD 2 (Quality Management) of Bureau of Indian Standards.
Recognized for her contributions to healthcare consulting and entrepreneurship, Ms. Venugopal was honored with the Best Women Healthcare Entrepreneur Award by the Indian Medical Association (IMA), Goa, in 2017.

Dr. Ray R.S

Scientific Assistant
Indian Pharmacopoeia Commission, Ministry of Health
& Family Welfare, Govt. of India

View Profile
×

Dr. Ray R.S

Scientific Assistant -Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India

Dr. R. S. Ray is a Scientific Assistant at Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt. of India. In his role as Scientific Assistant, he contributes to national efforts aimed at strengthening drug safety monitoring and ensuring the safe and rational use of medicines across the country.
With expertise in pharmacovigilance, drug safety monitoring, and adverse drug reaction (ADR) reporting systems, Dr. Ray has been actively involved in supporting the development and implementation of pharmacovigilance frameworks in India. His work contributes to the objectives of the Pharmacovigilance Programme of India, a nationwide initiative established to collect, analyze, and respond to adverse drug reactions in order to safeguard public health and enhance patient safety.
Dr. Ray has also participated in and supported multiple training and capacity-building initiatives in pharmacovigilance, helping healthcare professionals, researchers, and industry stakeholders strengthen their understanding of drug safety reporting and regulatory practices. These programmes aim to improve awareness and reporting culture among medical and pharmaceutical professionals across India.
In addition to his professional contributions, Dr. Ray has been involved in research activities in pharmacovigilance and drug safety, contributing to scientific publications that examine adverse drug reactions and pharmacovigilance practices. His work reflects a strong commitment to improving pharmacovigilance systems and advancing regulatory science in the pharmaceutical and healthcare sectors.
Through his ongoing efforts, Dr. Ray continues to play an important role in supporting India’s pharmacovigilance ecosystem and strengthening the country’s capacity to monitor and respond to drug safety concerns.

PARTNERS

SILVER PARTNER

ETQ

Veeva

Veeva Systems – Transforming Pharma through Cloud-Based Automation and Innovation.
Veeva Systems is a global leader in cloud-based software solutions for the life sciences industry. With a mission to help companies bring medicines and therapies to patients faster and more efficiently, Veeva delivers a comprehensive suite of solutions that spans the full product lifecycle—from research and development to commercialization.
Our industry-specific solutions are designed to meet the unique regulatory, quality, and compliance needs of pharmaceutical, biotech, and medical device companies. Veeva’s flagship applications, including Veeva Vault—the only cloud-based platform tailored for regulated industries—enable organizations to unify content and data management, streamline processes, and drive automation across the enterprise.
With deep expertise in the domains of quality, regulatory, clinical, commercial, and medical affairs, Veeva is trusted by more than 1,400+ companies globally, including emerging biotechs and the world’s largest pharmaceutical enterprises. Our suite of Quality applications, including Vault QMS, Vault QDocs, and Vault Training, Vault Validation Management, Valult LIMS, Vault Station Manager and Learn GxP is transforming the way life sciences companies manage quality processes, improving compliance, efficiency, and innovation.
Veeva’s commitment to customer success drives us to continuously innovate. Our cloud platform’s scalability, built-in compliance, and industry best practices help companies adapt to regulatory changes, reduce operational risks, and accelerate time to market.
Headquartered in Pleasanton, California, with offices around the world, Veeva Systems is dedicated to advancing the life sciences industry through automation, innovation, and collaboration.
Learn More



MEDIA PARTNERS

PAST EVENT PARTNERS